Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Jiwei Zhang1, Fen Ma1, Zhe Li2

  • 1Shanghai Key Laboratory of Compound Chinese Medicines The MOE Key Laboratory for Standardization of Chinese Medicines Institute of Chinese Materia Medica Shanghai University of Traditional Chinese Medicine Shanghai China.

MedComm
|April 25, 2024
PubMed
概括
此摘要是机器生成的。

核因子卡帕B亚单元2 (NFKB2) 通过升调PD-L1.1,促进结直肠癌 (CRC) 的生长和免疫逃生. 准NFKB2可能会提高CRC患者的免疫疗法的有效性.

相关实验视频

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

UDP-glucuronate decarboxylase 1 promotes tumor immune evasion by accelerating KMT2D loss in hepatocellular carcinoma.

Journal for immunotherapy of cancer·2026
Same author

A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity.

Nature biomedical engineering·2025
Same author

Notoginsenoside Ft1 inhibits colorectal cancer growth by increasing CD8<sup>+</sup> T cell proportion in tumor-bearing mice through the USP9X signaling pathway.

Chinese journal of natural medicines·2024
Same author

Single-cell profiling of the microenvironment in human bone metastatic renal cell carcinoma.

Communications biology·2024
Same author

Structural insights into gating mechanism and allosteric regulation of NMDA receptors.

Current opinion in neurobiology·2023
Same author

Cancer and Atrial Fibrillation Comorbidities Among 25 Million Citizens in Shanghai, China: Medical Insurance Database Study.

JMIR public health and surveillance·2023

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 分子生物学分子生物学